The Union: Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health
Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health
The 52nd Union World Conference on Lung Health is pleased to announce that submissions for Late-Breaker Sessions are open from 15 July-12 August 2021. Submit now.
In keeping with the spirit of a late-breaker session, we ask that only new, innovative and significant findings of broad interest that have occurred after 12 May, or for which information has just become available, be submitted for the late-breaker sessions.
The following three late-breaker sessions are slated for the Conference that will take place from 19-22 October 2021:
THE UNION LATE-BREAKER SESSION ON COVID-19
All aspects of SARS-CoV-2 and Covid-19-related lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, clinical trials for vaccines or therapeutics, to operational research in adults and children.
This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with the online audience.
THE UNION/CDC LATE-BREAKER SESSION ON TB
The 52nd Union World Conference on Lung Health and the United States Centers for Disease Control and Prevention (CDC) are pleased to announce a late-breaker session related to tuberculosis (TB).
This late-breaker session includes all aspects of TB prevention, diagnosis, and treatment research (including basic and clinical science, epidemiology, social, behavioural, and health care delivery). Given the global COVID-19 pandemic, we will also consider select presentations that explore the intersection of COVID-19 and TB prevention and programmatic implementation. It will consist of 7 pre-recorded oral presentations of 8 minutes each and live Q&A at the end of the session. The session is scheduled on 22 October 2021.
THE UNION STUDENT LATE-BREAKER SESSION ON LUNG HEALTH
The 52nd Union World Conference on Lung Health is pleased to announce the Union student late-breaker session focusing on lung health and sponsored by the Research Institute of Tuberculosis of the Japan Anti-Tuberculosis Association (RIT/JATA).
All aspects of lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, to operational research in tuberculosis (TB), Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and other lung health issues in adults and children. This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with online audience.
Individuals submitting an abstract must be currently enrolled as a student in a university programme at undergraduate, graduate, or doctoral level either full- or part-time.
DETAILS
All abstracts must follow the abstract submission guidelines
For more information and details on sponsorship for late-breaker sessions: https://theunion.org/late-breaker-sessions
For any further queries, email scientific@theunion.org
Submit now!
CARNEGIE AFRICAN DIASPORA FELLOWSHIP PROGRAM - APPLICATIONS DUE MONDAY 4 MARCH 2024
The Carnegie African Diaspora Fellowship Program (CADFP) is a fellowship program for African institutions in Ghana, Kenya, Nigeria, South Africa, Tanzania, Uganda and member institutions of the African Research Universities Alliance (ARUA) and partner universities with the Consortium for Advanced Research Training in Africa (CARTA) to host an African-born scholar to work on projects in research collaboration, graduate student teaching/mentoring and curriculum co-development. The application process has two parts.
The Carnegie African Diaspora Fellowship Program is a fellowship program that supports educational projects in African higher education institutions. This is an opportunity for African-born scholars living in the U.S. or Canada to travel to Africa to work on a project in one of the following: Innovations in curriculum co-development, new approaches and methods to graduate mentoring and training, and impactful research collaboration and capacity strengthening.
Applications due Monday, Mar. 4, 2024.
EUROPEAN HIV CLINICAL FORUM 2020: OPTIMIZING TREATMENT, 27 October 2020
The European HIV Clinical Forum 2020 provides an independent scientific program involving the world’s leading experts and is specifically designed for the European HIV healthcare professionals with the focus on optimizing treatment for their patients. The meeting is scheduled prior to the 18th European meeting on HIV & Hepatitis in Paris, France, which will allow healthcare professionals to combine both meetings in one trip thus limiting travel time and the number of days away from the clinic.
This program will feature challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program will end with a networking reception for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.
For more information visit https://www.hiv-clinical-forum.org/european-2020
AVMI Webinar: Bringing International Vaccine Manufacturing Expertise To Nigeria/Africa, 27 May 2021
Innovative Biotech - Bringing International Vaccine Manufacturing Expertise to Nigeria/Africa
Chair: Charles Kamau, Co-Chair AVMI Communications Working Group
Speaker: Dr Simon Agwale, CEO of Innovative Biotech, Nigeria and Innovative Biotech, USA Inc
Please find below the Zoom link to register your attendance for the upcoming webinar this week.
Zoom: https://us02web.zoom.us/webinar/register/WN_R8XQvK9oShu1GJiGbcePfQ
Date: Thursday, 27th May 2021
Time: 15h00 SAST | 13h00 GMT (60min)